| abstract |
Sodium channel modulating compounds are described, in particular NaV1.7 modulating compounds of formula I or formula I ′. In particular, a process for preparing such compounds, intermediates for the preparation of such compounds, pharmaceutical compositions containing such compounds, and methods of treatment comprising administering such compounds are described. In particular, compounds for the treatment of pain and diabetes are described. [Chemical 1] [Selection] Figure 2 |